Evolution of interferon-beta binding antibodies in MS patients may predict development of neutralizing antibodies.
Mayr
M
M
Berek
K
K
Deisenhammer
F
F
D000906:Antibodies / Q000032:analysis / Q000097:blood*; D000917:Antibody Formation; D006801:Humans; D016899:Interferon-beta / Q000009:adverse effects / Q000276:immunology* / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000097:blood / Q000188:drug therapy / Q000276:immunology*; D013997:Time Factors
D000906:Antibodies; D016899:Interferon-beta